Search Results - "WARREN, Diane L"

Multicenter, Phase I, Dose-Escalation Trial of Lenalidomide Plus Bortezomib for Relapsed and Relapsed/Refractory Multiple Myeloma by RICHARDSON, Paul G, WELLER, Edie, WARREN, Diane L, LUNDE, Laura E, MCKENNEY, Mary, DELANEY, Carol, MITSIADES, Constantine S, HIDESHIMA, Teru, DALTON, William, KNIGHT, Robert, ESSELTINE, Dixie-Lee, ANDERSON, Kenneth C, JAGANNATH, Sundar, AVIGAN, David E, ALSINA, Melissa, SCHLOSSMAN, Robert L, MAZUMDER, Amitabha, MUNSHI, Nikhil C, GHOBRIAL, Irene M, DOSS, Deborah

“…Lenalidomide and bortezomib are active in relapsed and relapsed/refractory multiple myeloma (MM). In preclinical studies, lenalidomide sensitized MM cells to…”
Get full text

Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma by Richardson, Paul G., Weller, Edie, Lonial, Sagar, Jakubowiak, Andrzej J., Jagannath, Sundar, Raje, Noopur S., Avigan, David E., Xie, Wanling, Ghobrial, Irene M., Schlossman, Robert L., Mazumder, Amitabha, Munshi, Nikhil C., Vesole, David H., Joyce, Robin, Kaufman, Jonathan L., Doss, Deborah, Warren, Diane L., Lunde, Laura E., Kaster, Sarah, DeLaney, Carol, Hideshima, Teru, Mitsiades, Constantine S., Knight, Robert, Esseltine, Dixie-Lee, Anderson, Kenneth C.

“…This phase 1/2 study is the first prospective evaluation of lenalidomide-bortezomib-dexamethasone in front-line myeloma. Patients (N = 66) received 3-week…”
Get full text

Tailoring treatment for multiple myeloma patients with relapsed and refractory disease by Richardson, Paul G, Laubach, Jacob, Mitsiades, Constantine, Schlossman, Robert L, Doss, Deborah, Colson, Kathleen, McKenney, Mary L, Noonan, Kimberly, Warren, Diane L, Ghobrial, Irene M, Munshi, Nikhil C, Anderson, Kenneth

“…Responses to treatment of relapsed and refractory multiple myeloma are characteristically short, and median survival is as brief as 6 months. Although…”
Get more information

Cholesterol Regulation and Statin Therapy in Patients with Waldenstrom's Macroglobulinemia by Ioakimidis, Thea, Patterson, Christopher J, Hunter, Zachary, Soumerai, Jacob, Manning, Robert, Warren, Diane L., Ghobrial, Irene, Sheehy, Patricia, Treon, Steven

“…Abstract 4789 Patients with WM commonly display low cholesterol levels, particularly LDL and VLDL levels. Given these observations, we examined their levels in…”
Get full text

High Response Rates and Encouraging Time-to-Event Data with Lenalidomide, Bortezomib, and Dexamethasone in Newly Diagnosed Multiple Myeloma: Final Results of a Phase I/II Study by Richardson, Paul G, Lonial, Sagar, Jakubowiak, Andrzej J, Jagannath, Sundar, Raje, Noopur S, Avigan, David E, Ghobrial, Irene, Schlossman, Robert L, Mazumder, Amitabha, Munshi, Nikhil C., Laubach, Jacob, Vesole, David, Joyce, Robin, Rosenblatt, Jacalyn, Xie, Wanling, Doss, Deborah, Warren, Diane L., Ittleman, Kate, Revta, Carolyn, Francis, Dixil, Leister, Charles, Kaster, Sarah, Delaney, Carol, Lauria, Marisa, Mitsiades, Constantine S., Hideshima, Teru, Knight, Robert, Esseltine, Dixie-Lee, Weller, Edie, Anderson, Kenneth C.

“…Abstract 1218 Poster Board I-240 The combination of lenalidomide (Len, Revlimid®), bortezomib (Bz, Velcade®), and dexamethasone (dex; RVD) has shown excellent…”
Get full text

Lenalidomide, Bortezomib, and Dexamethasone in Patients with Newly Diagnosed Multiple Myeloma: Encouraging Efficacy in High Risk Groups with Updated Results of a Phase I/II Study by Richardson, Paul, Lonial, Sagar, Jakubowiak, Andrzej, Jagannath, Sundar, Raje, Noopur S, Avigan, David, Ghobrial, Irene M, Schlossman, Robert L, Mazumder, Amitabha, Munshi, Nikhil C, Vesole, David H, Joyce, Robin, Doss, Deborah, Warren, Diane L, Hayes, Stephen W, Kaster, Sarah, Delaney, Carol, Lauria, Marisa, Mitsiades, Constantine, Hideshima, Teru, Knight, Robert D., Esseltine, Dixie-Lee, Anderson, Kenneth C

“…Background: Bortezomib (VELCADE®, Bz) is approved for the treatment of patients (pts) with multiple myeloma (MM). Lenalidomide (Revlimid®, Len) plus…”
Get full text

Strategies for an eighth-grade integrated language arts instructional framework by Warren, Diane L. Cook

Get full text

The prevalence of hypoxemia detected by pulse oximetry during recovery from anesthesia by Morris, R W, Buschman, A, Warren, D L, Philip, J H, Raemer, D B

“…Pulse oximetry was used to assess the prevalence of hypoxemia (arterial oxygen saturation of 90% or less) at various times in the immediate postoperative…”
Get full text

Hypoxemia during ambulatory gynecologic surgery as evaluated by the pulse oximeter by Raemer, D B, Warren, D L, Morris, R, Philip, B K, Philip, J H

“…Pulse oximetry was used to determine the incidence of intraoperative hypoxemia in 108 patients undergoing ambulatory gynecologic operation. Eleven (10%)…”
Get more information